Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9194 |
High Similarity |
NPD1201 |
Approved |
0.9098 |
High Similarity |
NPD5405 |
Approved |
0.9098 |
High Similarity |
NPD5408 |
Approved |
0.9098 |
High Similarity |
NPD5404 |
Approved |
0.9098 |
High Similarity |
NPD5406 |
Approved |
0.8913 |
High Similarity |
NPD7390 |
Discontinued |
0.8906 |
High Similarity |
NPD1470 |
Approved |
0.8741 |
High Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8582 |
High Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.806 |
Intermediate Similarity |
NPD1164 |
Approved |
0.8042 |
Intermediate Similarity |
NPD7003 |
Approved |
0.8015 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7984 |
Intermediate Similarity |
NPD2342 |
Discontinued |
0.7922 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7852 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7832 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7786 |
Intermediate Similarity |
NPD943 |
Approved |
0.777 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7756 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7722 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7687 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7676 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7639 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7591 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7586 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7584 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD5951 |
Approved |
0.7548 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7538 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7537 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7537 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7535 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7484 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7482 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7481 |
Intermediate Similarity |
NPD2286 |
Discontinued |
0.7481 |
Intermediate Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7448 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7448 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7426 |
Intermediate Similarity |
NPD3023 |
Approved |
0.7426 |
Intermediate Similarity |
NPD3026 |
Approved |
0.7419 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7407 |
Intermediate Similarity |
NPD3024 |
Approved |
0.7407 |
Intermediate Similarity |
NPD3025 |
Approved |
0.7389 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7386 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7381 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7365 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7273 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7237 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7237 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7231 |
Intermediate Similarity |
NPD74 |
Approved |
0.7231 |
Intermediate Similarity |
NPD9266 |
Approved |
0.723 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7226 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD6663 |
Approved |
0.72 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.719 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7186 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7186 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7185 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7183 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7181 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7154 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7154 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7154 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7154 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.712 |
Intermediate Similarity |
NPD288 |
Approved |
0.7095 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7092 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7083 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.708 |
Intermediate Similarity |
NPD3091 |
Approved |
0.7078 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7071 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7066 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7045 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7044 |
Intermediate Similarity |
NPD8438 |
Clinical (unspecified phase) |
0.704 |
Intermediate Similarity |
NPD844 |
Approved |
0.704 |
Intermediate Similarity |
NPD2859 |
Approved |
0.704 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7012 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD3092 |
Approved |
0.6994 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD6020 |
Phase 2 |
0.6981 |
Remote Similarity |
NPD2801 |
Approved |
0.6978 |
Remote Similarity |
NPD4059 |
Approved |
0.6977 |
Remote Similarity |
NPD1929 |
Approved |
0.6977 |
Remote Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD1930 |
Approved |
0.6963 |
Remote Similarity |
NPD4869 |
Clinical (unspecified phase) |
0.696 |
Remote Similarity |
NPD2933 |
Approved |
0.696 |
Remote Similarity |
NPD2934 |
Approved |
0.6959 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6957 |
Remote Similarity |
NPD9545 |
Approved |
0.6957 |
Remote Similarity |
NPD7075 |
Discontinued |
0.695 |
Remote Similarity |
NPD4878 |
Approved |
0.6939 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD6099 |
Approved |
0.6933 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD6100 |
Approved |
0.6923 |
Remote Similarity |
NPD4339 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD1203 |
Approved |
0.6917 |
Remote Similarity |
NPD3022 |
Approved |
0.6917 |
Remote Similarity |
NPD3021 |
Approved |
0.6912 |
Remote Similarity |
NPD497 |
Approved |
0.6908 |
Remote Similarity |
NPD2800 |
Approved |
0.6906 |
Remote Similarity |
NPD4093 |
Discontinued |
0.6906 |
Remote Similarity |
NPD5691 |
Approved |
0.6903 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6884 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6875 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6863 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6863 |
Remote Similarity |
NPD3400 |
Discontinued |
0.6849 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.6846 |
Remote Similarity |
NPD9261 |
Approved |
0.6838 |
Remote Similarity |
NPD496 |
Approved |
0.6838 |
Remote Similarity |
NPD498 |
Approved |
0.6838 |
Remote Similarity |
NPD495 |
Approved |
0.6832 |
Remote Similarity |
NPD2296 |
Approved |
0.6831 |
Remote Similarity |
NPD1608 |
Approved |
0.6822 |
Remote Similarity |
NPD289 |
Clinical (unspecified phase) |
0.6822 |
Remote Similarity |
NPD1242 |
Phase 1 |
0.6818 |
Remote Similarity |
NPD6534 |
Approved |
0.6818 |
Remote Similarity |
NPD6535 |
Approved |
0.6806 |
Remote Similarity |
NPD2797 |
Approved |
0.6806 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6803 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6803 |
Remote Similarity |
NPD411 |
Approved |
0.6797 |
Remote Similarity |
NPD1243 |
Approved |
0.6794 |
Remote Similarity |
NPD1237 |
Approved |
0.6792 |
Remote Similarity |
NPD6599 |
Discontinued |
0.679 |
Remote Similarity |
NPD3882 |
Suspended |
0.6788 |
Remote Similarity |
NPD9281 |
Approved |
0.6772 |
Remote Similarity |
NPD1809 |
Phase 2 |
0.6769 |
Remote Similarity |
NPD940 |
Approved |
0.6769 |
Remote Similarity |
NPD846 |
Approved |
0.6769 |
Remote Similarity |
NPD1932 |
Approved |
0.6768 |
Remote Similarity |
NPD5494 |
Approved |
0.6765 |
Remote Similarity |
NPD5029 |
Approved |
0.6765 |
Remote Similarity |
NPD5027 |
Approved |
0.6765 |
Remote Similarity |
NPD5031 |
Approved |
0.6757 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6753 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6748 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6746 |
Remote Similarity |
NPD845 |
Approved |
0.6738 |
Remote Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.6738 |
Remote Similarity |
NPD3095 |
Discontinued |
0.6733 |
Remote Similarity |
NPD6651 |
Approved |
0.6731 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6728 |
Remote Similarity |
NPD5616 |
Clinical (unspecified phase) |
0.6722 |
Remote Similarity |
NPD6780 |
Approved |
0.6722 |
Remote Similarity |
NPD6778 |
Approved |
0.6722 |
Remote Similarity |
NPD6782 |
Approved |
0.6722 |
Remote Similarity |
NPD6776 |
Approved |
0.6722 |
Remote Similarity |
NPD6777 |
Approved |
0.6722 |
Remote Similarity |
NPD6781 |
Approved |
0.6722 |
Remote Similarity |
NPD6779 |
Approved |
0.6716 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6713 |
Remote Similarity |
NPD9717 |
Approved |
0.6711 |
Remote Similarity |
NPD2438 |
Suspended |
0.6711 |
Remote Similarity |
NPD4477 |
Approved |
0.6711 |
Remote Similarity |
NPD4476 |
Approved |
0.6711 |
Remote Similarity |
NPD2531 |
Phase 2 |
0.6711 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.671 |
Remote Similarity |
NPD7910 |
Clinical (unspecified phase) |
0.6708 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6704 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6704 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6693 |
Remote Similarity |
NPD688 |
Clinical (unspecified phase) |
0.6693
|
Remote Similarity |
NPD1432 |
Clinical (unspecified phase) |